Skip to main content
. 2020 Jul 3;12(14):14978–14989. doi: 10.18632/aging.103557

Figure 6.

Figure 6

Inhibition of miR-152-3p enhanced HUVEC function. (A) The qRT-PCR result confirmed the effect of miR-152-3p agonist and antagonist on the expression of miR-152-3p. (B) CCK8 proliferation assay was performed, and the results demonstrated that proliferation of HUVECs was increased after miR-152-3p antagonist treatment. (C–D) The proliferation-related mRNAs in the different groups were measured using qRT-PCR and WB analyses. (E) The apoptosis-related mRNAs were assessed using qRT-PCR analysis. (F–H) Effects of miR-152-3p on the tube formation ability of HUVECs. Scale bar: 200 μm. Data are the mean ± SD of three independent experiments. *P <0.05, **P <0.01, ***P <0.001.